Skip to main content
. 2017 May 30;109(8):djx084. doi: 10.1093/jnci/djx084

Table 1.

Association results for prostate cancer risk variants at 13q34 and 22q12.1 in men of African ancestry

SNP ID chr. position* Nearby genes AAPC
Ghana
Kaiser/ProHealth
ELLIPSE OncoArray
Meta-analysis
Alleles OR (95% CI) P RAF§ OR (95% CI) P RAF§ OR (95% CI) P RAF§ OR (95% CI) P RAF§ OR (95% CI) P
rs75823044 IRS2 T/C 1.47 (1.22 to 1.76) 3.73 × 10‐5 0.022 2.66 (1.59 to 4.47) 2.04 × 10-4 0.029 1.27 (0.80 to 2.00) .31 0.021 1.60 (1.31 to 1.96) 4.84 × 10-6 0.020 1.55 (1.37 to 1.76) 6.10 × 10-12
13q34
110,360,784
rs78554043 CHEK2 C/G 1.60 (1.27 to 2.00) 5.02 × 10‐5 0.015 2.45 (1.33 to 4.52) .004 0.019 1.17 (0.69 to 1.99) .55 0.017 1.66 (1.30 to 2.13) 5.98 × 10-5 0.013 1.62 (1.39 to 1.89) 7.50 × 10-10
22q12.1
28,374,943
*

Genome build 37/HG19. chr. = chromosome; CI = confidence interval; OR = odds ratio; RAF = risk allele frequency.

Risk allele/reference allele.

Allele dosage effects were tested through a 1-degree of freedom Wald trend test. All P values are two-sided.

§

Risk allele frequency in controls.